Sorry, this entry is only available in Ukrainian and Russian.
Європейська Комісія подала пропозиції щодо реформування фармсектора
Вас может заинтересовать:
WEB only
The war is changing the situation on the drug market: there is a certain shortage with imported medicines, and many of the Western pharmaceutical companies are still operating in the…
WEB only
Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…
